{"success":true,"data":{"pressRelease":{"id":"40122","rtpr_id":"nWkrc0Xc0","ticker":"PMED","exchange":"","all_tickers":["PMED"],"title":"Peptonic Medical is expanding its portfolio in the intimate self-care category and launching VagiVital Intimate V Wipes","author":"Cision","published_at":"2026-05-20T06:00:06.330Z","article_body":"PEPTONIC Medical AB\nPeptonic Medical AB (publ) (“Peptonic” or “the Company”) is expanding\nits product portfolio in the intimate health category and launching VagiVital\nIntimate V Wipes, intimate wipes specially developed for gentle cleansing of\nthe external areas of the intimate region. The launch is part of Peptonic’s\nstrategy to develop VagiVital into a stronger and broader brand in intimate\ncare, with products for a variety of everyday needs.\n\nThe launch is a strategically important step in Peptonic’s ambition to\ndevelop VagiVital into a leading, comprehensive brand in intimate self-care,\nwith products that meet women’s needs throughout all stages and situations\nof life.\n\nWith VagiVital Intimate V Wipes, Peptonic is expanding its offering from\ntreatment and moisturizing products to include practical premium products for\ndaily intimate care and an active lifestyle.\n\n“We are very pleased to be able to expand our range with VagiVital Intimate\nV Wipes—a product that has been requested by our customers and that\ncomplements our existing portfolio in a natural and strategic way. Our vision\nis to establish VagiVital as the obvious first choice in intimate self-care,\nwith innovative products that combine quality, safety, and\nuser-friendliness,” says Daniel Rudeklint, interim CEO of Peptonic Medical\nAB.\n\nVagiVital Intimate V Wipes are exclusively developed for external intimate\ncare and contain glycerin to moisturize the skin, as well as a pre- and\nprobiotic complex that helps support the skin’s natural balance. The product\nleaves the skin clean, fresh, and soft while contributing to a pleasant sense\nof comfort and well-being.\n\nThe launch strengthens Peptonic’s position in modern intimate self-care and\nis a step toward making intimate care more accessible, less stigmatized, and\nintegrated into women’s daily lives.\n\nIntimate V Wipes are scheduled to launch in the second half of 2026.\n\nFor further information, please contact:\n\nDaniel Rudeklint, Interim CEO, Peptonic Medical AB\n\nEmail: daniel.rudeklint@peptonicmedical.se\n\nPhone: +46 73 158 02 73\n\nAbout Peptonic Medical AB\n\nPeptonic Medical AB (publ) is a Swedish medical technology company that\ndevelops and sells clinically proven self-care products for women’s intimate\nhealth. Under the VagiVital and Vernivia brands, the Company offers an\nover-the-counter portfolio of effective and gentle products that help women\nunderstand, treat, and prevent common gynecological conditions. Peptonic’s\ngrowth strategy is based on geographic expansion, particularly in the U.S. and\nEurope, and on continuously strengthening the product portfolio through\nin-house product development and strategic acquisitions.\n\nThe Company is headquartered in Stockholm, Sweden, and has subsidiaries\nPeptonic Medical Inc. and Common Sense Marketing Inc. in the U.S. Peptonic\nMedical was founded in 2009 and has been listed on the Spotlight Stock Market\nsince 2014.\n\nhttps://news.cision.com/peptonic-medical-ab/r/peptonic-medical-is-expanding-its-portfolio-in-the-intimate-self-care-category-and-launching-vagivit%2Cc4350422\n\n\n\n(c) Copyright Waymaker BIT News - Cision 2026","article_body_html":"","raw_payload":{"data":{"id":"nWkrc0Xc0","title":"Peptonic Medical is expanding its portfolio in the intimate self-care category and launching VagiVital Intimate V Wipes","author":"Cision","ticker":"PMED","created":"2026-05-20T06:00:06.330Z","tickers":["PMED"],"exchange":"","article_body":"PEPTONIC Medical AB\nPeptonic Medical AB (publ) (“Peptonic” or “the Company”) is expanding\nits product portfolio in the intimate health category and launching VagiVital\nIntimate V Wipes, intimate wipes specially developed for gentle cleansing of\nthe external areas of the intimate region. The launch is part of Peptonic’s\nstrategy to develop VagiVital into a stronger and broader brand in intimate\ncare, with products for a variety of everyday needs.\n\nThe launch is a strategically important step in Peptonic’s ambition to\ndevelop VagiVital into a leading, comprehensive brand in intimate self-care,\nwith products that meet women’s needs throughout all stages and situations\nof life.\n\nWith VagiVital Intimate V Wipes, Peptonic is expanding its offering from\ntreatment and moisturizing products to include practical premium products for\ndaily intimate care and an active lifestyle.\n\n“We are very pleased to be able to expand our range with VagiVital Intimate\nV Wipes—a product that has been requested by our customers and that\ncomplements our existing portfolio in a natural and strategic way. Our vision\nis to establish VagiVital as the obvious first choice in intimate self-care,\nwith innovative products that combine quality, safety, and\nuser-friendliness,” says Daniel Rudeklint, interim CEO of Peptonic Medical\nAB.\n\nVagiVital Intimate V Wipes are exclusively developed for external intimate\ncare and contain glycerin to moisturize the skin, as well as a pre- and\nprobiotic complex that helps support the skin’s natural balance. The product\nleaves the skin clean, fresh, and soft while contributing to a pleasant sense\nof comfort and well-being.\n\nThe launch strengthens Peptonic’s position in modern intimate self-care and\nis a step toward making intimate care more accessible, less stigmatized, and\nintegrated into women’s daily lives.\n\nIntimate V Wipes are scheduled to launch in the second half of 2026.\n\nFor further information, please contact:\n\nDaniel Rudeklint, Interim CEO, Peptonic Medical AB\n\nEmail: daniel.rudeklint@peptonicmedical.se\n\nPhone: +46 73 158 02 73\n\nAbout Peptonic Medical AB\n\nPeptonic Medical AB (publ) is a Swedish medical technology company that\ndevelops and sells clinically proven self-care products for women’s intimate\nhealth. Under the VagiVital and Vernivia brands, the Company offers an\nover-the-counter portfolio of effective and gentle products that help women\nunderstand, treat, and prevent common gynecological conditions. Peptonic’s\ngrowth strategy is based on geographic expansion, particularly in the U.S. and\nEurope, and on continuously strengthening the product portfolio through\nin-house product development and strategic acquisitions.\n\nThe Company is headquartered in Stockholm, Sweden, and has subsidiaries\nPeptonic Medical Inc. and Common Sense Marketing Inc. in the U.S. Peptonic\nMedical was founded in 2009 and has been listed on the Spotlight Stock Market\nsince 2014.\n\nhttps://news.cision.com/peptonic-medical-ab/r/peptonic-medical-is-expanding-its-portfolio-in-the-intimate-self-care-category-and-launching-vagivit%2Cc4350422\n\n\n\n(c) Copyright Waymaker BIT News - Cision 2026"},"type":"article","timestamp":"2026-05-20T06:00:07.04395566Z","server_sent_at_ms":1779256807043},"received_at":"2026-05-20T06:00:07.133Z","source_url":"https://news.cision.com/peptonic-medical-ab/r/peptonic-medical-is-expanding-its-portfolio-in-the-intimate-self-care-category-and-launching-vagivit%2Cc4350422"},"analysis":{"id":"29560","press_release_id":"40122","analysis_json":{"industry":{"label":"Pharmaceuticals, Biotechnology & Life Sciences","sector":"Health Care"},"redFlags":[],"eventType":"product_launch","narrative":"Peptonic Medical is launching VagiVital Intimate V Wipes, expanding its portfolio from treatment products to include daily care items.\n\nThe product contains glycerin and a pre- and probiotic complex, targeting external intimate cleansing for women.\n\nLaunch is scheduled for the second half of 2026, supporting the company's strategy to broaden the VagiVital brand.","sentiment":"bullish","agentHooks":{"shouldPost":false,"suggestedAngle":"Portfolio expansion into daily care category; low immediate market impact."},"keyFigures":{},"quotedText":"We are very pleased to be able to expand our range with VagiVital Intimate V Wipes—a product that has been requested by our customers and that complements our existing portfolio in a natural and strategic way.","namedEntities":{"people":[{"name":"Daniel Rudeklint","role":"Interim CEO"}],"products":["VagiVital Intimate V Wipes","VagiVital","Vernivia"],"companies":[{"name":"Peptonic Medical AB","ticker":"PMED","relationship":"filer"},{"name":"Peptonic Medical Inc.","relationship":"subsidiary"},{"name":"Common Sense Marketing Inc.","relationship":"subsidiary"}],"dollarAmounts":[]},"materialImpact":{"score":2,"reasoning":"Routine product launch expanding an existing brand portfolio. While strategically aligned with growth goals, it is a standard operational update without immediate financial impact or binary risk."},"tickerRelevance":{"others":[],"primary":"PMED"},"globalImportance":15,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"routine_product_launch","sectorWeight":"niche_healthcare","householdBrandBoost":0,"marketCapAdjustment":"low"}},"event_type":"product_launch","event_type_secondary":null,"sentiment":"bullish","material_impact_score":2,"narrative":"Peptonic Medical is launching VagiVital Intimate V Wipes, expanding its portfolio from treatment products to include daily care items.\n\nThe product contains glycerin and a pre- and probiotic complex, targeting external intimate cleansing for women.\n\nLaunch is scheduled for the second half of 2026, supporting the company's strategy to broaden the VagiVital brand.","key_figures":{},"named_entities":{"people":[{"name":"Daniel Rudeklint","role":"Interim CEO"}],"products":["VagiVital Intimate V Wipes","VagiVital","Vernivia"],"companies":[{"name":"Peptonic Medical AB","ticker":"PMED","relationship":"filer"},{"name":"Peptonic Medical Inc.","relationship":"subsidiary"},{"name":"Common Sense Marketing Inc.","relationship":"subsidiary"}],"dollarAmounts":[]},"model_name":"qwen3_6_27b_awq","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-05-20T06:01:30.536Z","global_importance":15,"audience_relevance":10,"importance_components":{"tickerTier":"small-cap","eventGravity":"routine_product_launch","sectorWeight":"niche_healthcare","householdBrandBoost":0,"marketCapAdjustment":"low"}},"durationMs":17994,"modelName":"george-droid-qwen-72b"}}